The activity of protein kinases is often regulated in an intramolecular fashion by signaling domains, which feature several phosphorylation or protein-docking sites. How kinases integrate such distinct binding and signaling events to regulate their activities is unclear, especially in quantitative terms. We used NMR spectroscopy to show how structural elements within the Abl regulatory module (RM) synergistically generate a multilayered allosteric mechanism that enables Abl kinase to function as a finely tuned switch. We dissected the structure and energetics of the regulatory mechanism to precisely measure the effects of various activating or inhibiting stimuli on Abl kinase activity. The data provide a mechanistic basis explaining genetic observations and reveal a previously unknown activator region within Abl. Our findings show that drug-resistance mutations in the Abl RM exert their allosteric effect by promoting the activated state of Abl and not by decreasing the drug affinity for the kinase.
Abl kinase is involved in a number of signaling pathways that control cell growth, survival, invasion, adhesion and migration [1] [2] [3] [4] [5] . In Abl [6] [7] [8] , as in the other human cytoplasmic tyrosine kinases 9, 10 , inhibition and activation are regulated allosterically through intramolecular interactions involving modular domains such as the SH3 and SH2 domains and the kinase domain (KD) (Fig. 1a) . Mutations or deletions in the Abl regulatory module (RM) give rise to aberrant forms of Abl, such as Bcr-Abl, that cause leukemia and other cancers 11 . Even relatively small increases in activity are sufficient for Abl to cause or mediate tumorigenesis 12 . Abl RM provides binding sites for the anchoring of adaptor proteins as well as sites that are phosphorylated by other kinases, processes that further regulate Abl activity 2, 5 (Fig. 1a) . Several mutations that confer resistance to the drug imatinib, a KD inhibitor, are located in the RM 13, 14 , but their mechanisms of action remain elusive.
The Abl RM has been observed to dock onto the KD in two distinct modes: in the assembled state 6, 8, 15 , the N-terminal myristoyl group is inserted into a pocket in the C lobe and stabilizes the docking of the RM at the back of the KD, thus giving rise to an autoinhibited form ( Fig. 1b) ; in the extended state, the SH2 domain binds to the top of the N lobe of the KD, thus yielding an activated kinase form (Fig. 1c) . The extended Abl conformation [15] [16] [17] is the most active form of Abl and has been associated with drastically increased leukemogenic activity 14, 16, 18 . Transitions between the inhibited and activated states are central in Abl regulation but are poorly understood. Abl, like many other kinases, is known to function in a graded manner rather than as a simple on/off switch 19, 20 . Given the dynamic nature of protein kinases [21] [22] [23] , insight into their conformational and energetic landscape [24] [25] [26] is required to fully understand the underlying mechanisms of regulation and how kinases respond to diverse signals.
RESULTS

Structures of the Abl RM activating and inhibiting states
The Abl RM consists of five distinct regions ( Fig. 1a) : an unstructured N-terminal region referred to as the cap (residues 1-80); the SH3 domain (residues 85-138); a short linker referred to as the connector SH3/2 (residues 139-152), which links the SH3 domain to the SH2 domain (residues 153-237); and a linker (linker SH2-KD ; residues 238-250) that connects the SH2 to the KD (residues 255-534) 8 . To delineate the conformational landscape of Abl RM, we used NMR 27, 28 to determine the intrinsic structural and dynamic properties of the isolated Abl RM (residues 1-255) ( Supplementary Fig. 1a,b) . NMR structure determination ( Table 1) showed that the isolated Abl RM adopts two distinct conformations in solution ( Fig. 1d,e ). In one of the conformations (Fig. 1d) , Abl RM adopts a structure very similar to the one seen in the assembled Abl kinase 8 (Fig. 1b) . In that conformation, the linker SH2-KD is bound to the polyproline II (PPII)-binding site of the SH3 domain, and the C-terminal region of the cap (hereafter cap C ; residues 65-75) interacts with the SH2 domain, whereas the cap region consisting of residues 1 through 63 is disordered and flexible (Fig. 1d) . This finding revealed that the isolated Abl RM intrinsically adopts the conformation conducive to the inhibited, assembled form of Abl 29 (Fig. 1b) . We will refer to this conformation of Abl RM as the 'inhibiting' state.
The second conformation that the isolated Abl RM adopts in solution ( Fig. 1e) is drastically different from the inhibiting conformation. Most notably, the crucial interaction between the linker SH2-KD and SH3 is disrupted, and the canonical PPII-binding site of the SH3 domain is instead engaged by the cap region comprising residues 14-20 (hereafter cap PxxP ), which carries a PxxP sequence motif, a preferred binding site of the Abl SH3 domain 30 (Figs. 1e and 2a ). In this second conformation, compared with the inhibiting state ( Fig. 1d) , A r t i c l e s the SH3 domain undergoes an ~25-Å translation and a ~45° rotation relative to the SH2 domain ( Fig. 2a) . As a result of this reorientation, SH3 clamps down on SH2, and cap C cannot engage the SH2 domain ( Figs. 1e and 2b) . Notably, in this conformation, Abl RM cannot interact optimally with the back of the KD, as seen in the assembled structure ( Supplementary Fig. 2a-c) . Instead, this structure is compatible with the activated state of Abl in the extended conformation ( Fig. 1e and Supplementary Fig. 2d-f ). Thus, we will refer to the second conformation of Abl RM as the 'activating' state ( Fig. 1e) . Formation of the extended Abl conformation necessitates the displacement of the linker SH2-KD from the SH3 domain, and thus the RM in only the activating state, but not in the inhibiting state, is compatible with the extended form of Abl ( Supplementary Fig. 2d-f) .
Notably, our data showed that cap PxxP is an intramolecular SH3binding site that can compete with and displace the linker SH2-KD from the SH3 domain, thereby destabilizing the inhibiting state ( Fig. 2c) . Cap PxxP appears to form a larger number of contacts with SH3 than does the linker SH2-KD , thereby explaining its ability to compete with the linker SH2-KD for SH3, despite the proximity of the linker to the SH3-binding site (Fig. 2b) . Thus, cap PxxP constitutes a previously undescribed activating region within Abl.
Dissection of the multilayered regulatory mechanism
The transition of Abl RM between the inhibiting and activating states is clearly a central process in the activity regulation of Abl kinase. The drastically different arrangement of key structural elements (linker SH2-KD , cap PxxP , cap C and the connector SH3/2 ) in the inhibiting and activating Abl RM states (Figs. 1d,e and 2) suggested that these elements influence the relative stability of the two functional states of Abl RM. The NMR data showed that the two states were in equilibrium in solution and interconverted rapidly (Online Methods and described below). We thus sought to dissect the contribution of each of the structural elements to the structure and energetics by characterizing a number of Abl variants. On the basis of the structures of the two states, the variants were designed to disrupt or enhance key intramolecular interactions within Abl RM ( Fig. 3) . A detailed NMR analysis ( Supplementary Fig. 1 ) of these variants showed that a large number of residues, especially those located in the connector SH3/2 , were particularly sensitive to even slight changes in the overall structure of Abl RM and were thus excellent probes of the Abl RM conformational ensemble (Online Methods). The chemical-shift responses of all these residues in the variants was very similar, as exemplified by Lys143, whose resonance in the 1 H-15 N HSQC spectra was located in a relatively uncrowded region and therefore was easy to monitor ( Fig. 3a) .
The linker SH2-KD mediates the juxtaposition of the SH3 domain onto the kinase domain and is thus one of the most important structural regions in Abl regulation 29, [31] [32] [33] [34] . Optimizing the binding interface between the linker SH2-KD and the SH3 by mutating the suboptimal Thr243 to proline 29 A r t i c l e s state. Indeed, NOESY analysis of Abl RM T243P showed the presence of solely the inhibiting state, and Lys143 in Abl RM T243P underwent a large chemical-shift change consistent with a pronounced shift of the equilibrium toward the inhibiting state ( Fig. 3a, peak 1→7 ). In contrast, the double P242E P249E mutation, known to activate Abl 31 , disrupted the binding of the linker SH2-KD to SH3, and NMR showed a pronounced shift toward the activating state, with the Lys143 resonance in Abl RM P242E P249E shifting in the opposite direction from that observed in Abl RM T243P ( Fig. 3a , peak 1→13). Deletion of the linker SH2-KD (Abl RM ∆linker ) shifted the equilibrium further toward the activating state ( Fig. 3a , peak 1→2).
Our structural data showed that the cap PxxP displaced the linker SH2-KD from the SH3 domain, thereby favoring the activating state ( Figs. 1e  and 2a,b) . Indeed, NMR analysis showed that deletion of cap PxxP (Abl RM ∆capPxxP ) shifted the equilibrium toward the inhibiting state ( Fig. 3a, peak 1→3) . In contrast to cap PxxP , which favors the activating state, cap C is expected to favor the inhibiting state 15 , wherein it acts as a clamp on the SH2 while being disordered in the activating state (Figs. 1d,e and 2a,b). In agreement with this hypothesis, deletion of cap C shifted the equilibrium toward the activating state ( Fig. 3a , peak 3→5 and peak 4→6).
The connector SH2-KD plays a central role in Abl regulation, as has been highlighted by a number of previous reports 7, 26, 35, 36 . The S140R/I substitution in particular causes a pronounced increase in Abl activity and results in increased resistance to the KD inhibitor imatinib 7, 13 . Notably, the NMR data showed that the S140R and S140I substitutions in Abl RM markedly favored the activating state ( Fig. 3a, peak 1→11 ), and NOESY experiments showed the presence of solely the activating state. Analysis of the Abl RM structural data revealed that the substitutions favored the activating state by forming either hydrogen bonds (Arg140) or hydrophobic contacts (Ile140) ( Fig. 2d) .
NMR analysis of the entire Abl kinase unit (residues 1-534, hereafter Abl) ( Fig. 3a and Supplementary Fig. 1a ,c) demonstrated that the conformational landscape of the RM in the context of Abl kinase was very similar to that described above for the isolated RM ( Fig. 3a) . This similarity was further supported by the observation that the Lys143 chemical shifts in Abl and its variants were very similar to those in the corresponding variants of the isolated RM ( Fig. 3a) . We used NMR to directly monitor the assembled and the extended conformations of Abl in solution. The resonances of Met263 and Met515 provided excellent probes, because they were located at the binding interface between the N lobe and the SH2 and the interface between the C lobe and the SH2, respectively (Fig. 4a,b and Supplementary  Fig. 3a) . The NMR chemical-shift data, combined with NOESY data, demonstrated that Abl populates both the assembled (inhibited) and extended (activated) states in solution, which are in equilibrium and interconvert rapidly ( Fig. 4a and Supplementary Fig. 3a,b) .
On the basis of the crystal structure, it has been suggested that the T231R substitution stabilizes the extended state via a salt bridge between Arg231 (in SH2) and Glu294 (in the N lobe), thereby enhancing Abl activity 14, 16, 17, 37, 38 . Our NMR spectra showed that the population of the extended state increased substantially in Abl T231R , an imatinib-resistant Abl variant, compared with wild-type Abl ( Fig. 4a and Supplementary Fig. 3a ). Amino acid substitutions in Abl that affected the SH3-linker SH2-KD binding interface and thus the equilibrium between the inhibiting and the activating states of Abl RM had a direct and pronounced effect on the populations of the assembled and the extended states. For example, the double P242E P249E substitution increased the population of the extended state, whereas the T243P substitution increased the population of the assembled state ( Fig. 4a and Supplementary Fig. 3a ). The present data revealed a direct link between the conformations of the RM (inhibiting versus activating) and the conformations of the entire Abl (assembled versus extended) ( Supplementary Fig. 3c ).
Energy landscape of the Abl RM
Of note, the NMR resonances of Abl RM residues in all of the characterized variants lay along the linear trajectory between the inhibiting and activating states ( Fig. 3a and Supplementary Fig. 3d-f) . This observation provides a strong indication that Abl RM populates only these two states in solution. Changes in populations affected by mutations in one of the structural elements, for example, linker-SH2 KD , were reflected in all other structural elements, such as cap C (Supplementary Fig. 3d-f) , thus further corroborating a cooperative two-state transition for Abl RM. Given that the interconversion occurred in the fast-exchange regime, the observed chemical shift (δ obs ) represents population-weighted averaging, and thus the population (p) of the two states can be extracted with the equation δ obs = δ I p I + δ A p A (refs. [39] [40] [41] , wherein I and A denote the inhibiting state and the activating state, respectively (Online Methods). In addition, the contribution of each variant to the energetics of the two Abl RM states can be determined with the equation ∆∆G I→A = −RT × ln(p A /p I ) ( Fig. 3b and Online Methods), where ∆∆G is the relative change in the free energy of the two states, and p A and p I are the populations of the activating and inhibiting states. Similarly, the NMR resonances of KD residues reporting on the assembled and extended states of Abl (for example, Met263 in Fig. 4a ) can be used to determine the population and energetics of these two functional states of Abl in solution ( Fig. 4a,b) . A r t i c l e s Notably, the relative stability of the inhibiting and activating states in the wild-type Abl RM was roughly equal, and thus the two states were almost equally populated ( Figs. 3b and 4c) . RM lay in the steepest region of the sigmoidal energy curve, thus rendering RM an ideal switch, because even subtle structural alterations associated with small energy changes would give rise to substantial changes in the population of the inhibiting/activating states ( Figs. 3b and 4c) . For example, a change in free energy of just 0.6 kcal mol −1 would result in a population change of 50% (Figs. 3b and 4c and refs. 42, 43) . Therefore, RM forms a powerful and sensitive switch that responds to even small structural and energetic changes and consequently regulates Abl kinase activity.
Of note, the intrinsic preference of the simple SH3-SH2 module (RM ∆cap ∆linker ), in the absence of the flanking cap and linker SH2-KD regions, was toward the activating state and exhibited a population of 81%, versus 19% for the inhibiting state (∆∆G ≈ 0.8 kcal mol −1 (peak 6 in Fig. 3a,b) . The structural element with the strongest effect on shifting the RM toward the inhibiting state was the linker SH2-KD , which stabilized the inhibiting state by up to ~2.1 kcal mol −1 (Fig. 3c) . Amino acid substitutions at the linker SH2-KD stabilized (for example, T243P) or destabilized (for example, P242E P249E) the inhibiting state ( Fig. 3c , positive or negative ∆∆G) and modulated the equilibrium, thus generating a range of populations between ~20% and 99% for the inhibiting state (Fig. 3b) . For example, the P249E substitution decreased the population of the inhibiting state to ~40%, and the double P242E P249E substitution decreased the population even further, to ~35%.
Our NMR data demonstrated that the cap C region stabilized the inhibiting state by as much as ~0.4 kcal mol −1 (Fig. 3c) . This result was in agreement with the structural data (Fig. 1b,c) showing that cap C acts as a linchpin in the inhibiting state but is disordered and dynamic in the activating state. Deletion of cap C favored the activating The four cap C residues that contact SH2 are Trp67, Lys70, Leu73 and Leu74. (c) Superposition of the structure of SH3 bound to the linker SH2-KD (inhibiting state) and bound to the cap PxxP motif (activating state). The SH3 domain is shown as a solvent-accessible surface in blue, the linker SH2-KD in red ball-and-stick representation and the cap PxxP in cyan ball-and-stick representation. The first few contacts to SH3 are very similar. Lys241, Pro242 and Val244 residues of the linker SH2-KD are substituted by Arg14, Pro15 and Leu17 in cap PxxP , thus forming very similar contacts with SH3. However, whereas the Tyr245 side chain in linker SH2-KD is pointing toward the solvent, the topologically equivalent Pro18 in cap PxxP forms close contacts with SH3. The contacts between SH3 and the linker SH2-KD residues Val247, Pro249 and Asn250 are substituted by contacts with residues Ala19, Leu20 and Ile23 in cap PxxP . Moreover, His21 and Phe22 provide additional contacts to SH3. (d) Structural basis for the stabilization of the activating state by the S140R mutation. Arg140 forms a bifurcated hydrogen bond with Tyr112 (in the SH3) and Tyr147 (in the SH2) in the activating state.
A r t i c l e s state and thereby the extended state in Abl by increasing its population from ~30% to ~50% (Figs. 3b and 4c) . In contrast, the cap PxxP had an effect opposite from that of cap C , because it stabilized the activating state by as much as ~0.4 kcal mol −1 (Figs. 3b,c and 4c) , by displacing the linker SH2-KD from SH3, thus resulting in the destabilization of the inhibiting state. Optimizing the SH3-cap PxxP interface, for example, by the S16P substitution (Fig. 2b) , further favored the activating state ( Fig. 3a,b ; peak 1→16).
As discussed above, the connector SH3/2 exerted a major effect by stabilizing the inhibiting state. Indeed, the NMR data showed that the S140R substitution in the connector SH3/2 favored the activating state by up to ~1.1 kcal mol −1 (Fig. 3c) . Collectively, our data demonstrated that the linker SH2-KD and the connector SH3/2 had the strongest effect on the energetics of the Abl RM inhibiting and activating states, and thus of the Abl assembled and extended states, whereas cap C and cap PxxP had a significant, albeit weaker effect (Fig. 3c) .
Allosteric drug-resistance mutations
Despite the success in treating chronic myelogenous leukemia by targeting Bcr-Abl with the inhibitor imatinib, a common problem is the development of drug resistance in many patients 3 . Several of these mutants are found in the Abl RM 13, 14 and are thus located far from the drug-binding site (Figs. 1a and 5a) . How these mutants exert their allosteric effect cannot be rationalized on the basis of existing structural data, and thus the underlying mechanism is not understood 13, 44 . We used isothermal titration calorimetry to measure the A r t i c l e s thermodynamics of imatinib binding to the Abl variants. The data showed that imatinib bound with the same affinity to the wild type and the Abl variants (Fig. 5b) . Even the individual thermodynamic components (∆H and ∆S) were essentially identical, thus indicating that, unlike the mutants with alterations in the KD drug-binding pocket 44 , the allosteric drug-resistant mutants in the RM exhibited no effect on imatinib binding. Notably, our NMR data revealed that the allosteric mutants altered the population of inhibited and activated states. Amino acid substitutions in the connector region (V138G, S140R and S140I) and in the linker SH2-KD (P242E and P249E) gave rise to a substantially increased activated-state population (Fig. 5c) . Thus, the allosteric drug-resistant mutants did not interfere directly with imatinib binding but instead promoted the activated state, thereby giving rise to higher overall kinase activity and compromising the inhibitory function of imatinib. GNF5 is a potent allosteric inhibitor that binds the myristic pocket of the C lobe 45 and elicits the same conformational change in the C lobe of KD as does myristic acid 8 . This conformational change enables the docking of the SH2 to the back of the C lobe. The NMR data showed that GNF5 binding to Abl drastically shifts the equilibrium toward the assembled, inhibited state (Fig. 4a) . Thus, our findings clearly demonstrated that this allosteric drug 45, 46 exerts its inhibitory effect by increasing the population of the assembled Abl, thus decreasing the activated-state population.
Abl RM functions as a graded switch
We observed an excellent correlation between the population of the activated state and the relative kinase activity of Abl variants (Fig. 6a) . The largest population of the activated state was measured for Abl T231R (~99%, Fig. 4c) , which exhibited the highest kinase activity, followed by Abl S140R and Abl P242E/P249E variants (Fig. 6a) . On the opposite end, the complex of Abl with the allosteric drug GNF5 exhibited a negligible kinase activity (Fig. 6a) , which was correlated with a low population (~5%) in the activated state (Fig. 4c) . The lowest kinase activity, as also reported previously 7 , was shown by the myristoylated form of Abl (Abl myr ) (Fig. 6a) . Although preparation of a highly homogeneous Abl myr sample for NMR studies has not been possible, the linear correlation produced here between the activated-state population and the kinase activity (Fig. 6a) provided an excellent tool to estimate the activated-state population in Abl myr . Using this correlation (Fig. 6a) , we estimated that the population in the activated state in Abl myr was ~2-3%. Interestingly, the Abl myr-T243P mutant exhibited further suppressed kinase activity, thus suggesting an equilibrium between the activated and inhibited states even in Abl myr (Fig. 6b) . Notably, analysis of the Abl myr structure indicated that the cap linker was sufficiently long to allow formation of the extended structure even when myristic acid was bound to the C lobe (Supplementary Fig. 2g ). In agreement, the S140R and P242E P249E substitutions markedly increased the kinase activity of Abl myr (Fig. 6b) . This behavior was reminiscent of the activation of Src kinase by substitutions that cause the linker SH2-KD to be displaced even when the SH2 is still bound to the phosphorylated C tail 47 .
Response of Abl to physiological activation signals
Abl's activity is stimulated by the binding of scaffold proteins such as Crk 48 , as well as by phosphorylation by other kinases (for example, Src 49 ). Crk, a scaffold protein consisting of a tandem SH2-SH3-SH3, binds through its middle SH3 domain to the proline-rich Crk-binding sites located at the disordered C-terminal tail of Abl 50,51 (Fig. 1a) and uses its SH2 domain to bind to the linker SH2-KD (ref. 52). Our NMR data showed that disruption of the SH3-linker SH2-KD interface caused by Crk binding to Abl strongly shifted the equilibrium toward the activated state (population ~70%) and thus gave rise to enhanced kinase activity ( Figs. 3a and 4a,b) . Src kinase is known to phosphorylate Tyr245 and to stimulate Abl activity 32, 49, 53, 54 . The NMR data showed a significant increase in the population of the activated state after phosphorylation by Src (Figs. 3, 4 and 6a) , which was caused by the displacement of the SH3 domain from the back of the kinase, owing to the steric hindrance induced by Tyr245 phosphorylation (Supplementary Fig. 2h,i) . A r t i c l e s
DISCUSSION
Quantitative descriptions of allosteric mechanisms in multidomain proteins are generally lacking. The present data provide an atomic view and quantitative description of the energy landscape in the allosteric regulation of the Abl kinase (Fig. 6c) . The kinase is inhibited and activated through a fine balance of energetic contributions from several structural elements in the regulatory module that cooperatively form a multilayered regulatory mechanism. The Abl RM makes an ideal switch for several reasons. (i) It is thermodynamically in a regime that allows for efficient suppression or activation by even small changes in energy. (ii) It adopts only two structures (activating and inhibiting), and a simple population shift between the two states enables Abl to function as a graded switch. (iii) Perturbations to the individual structural elements making up the multilayered regulatory mechanism act synergistically and can be additive or opposing, thus giving rise to any possible population in the continuum between full suppression and full activity. (iv) The kinetics of the switch interconversion is fast, thereby allowing for a rapid response to various signals and stimuli. (v) The presence of several structural elements that modulate the conformational equilibrium of the inhibited and activated states provides multiple avenues, via binding or phosphorylation processes, throughout the structure of the RM, thus affecting the equilibrium and hence the kinase activity. Such a regulatory mechanism may be common among the family of cytosolic tyrosine kinases, which share very similar overall structural architectures.
A multilayered regulatory mechanism has also been identified to modulate the activity of the proto-oncogene Vav1, a guanine nucleotide exchange factor 40, 55 . This multidomain protein exists in an equilibrium controlled by both thermodynamics and kinetics. The studies revealed a dynamic interplay among the domains of the protein that allows for transient exposure and phosphorylation of critical tyrosine residues relieving inhibition.
The kinetics of interconversion between the inhibiting and activating states of Abl RM is very fast, with an exchange rate (k ex ) much greater than 1,500 s −1 , as estimated by NMR. Thus, the structural elements that make up the multilayered regulatory mechanism, and serve as binding or phosphorylation sites, are ideally suited to function as regulatory hotspots because they allow for quick access to activators or inhibitors, thereby enabling Abl to respond rapidly to various signals and stimuli. Rapid phosphorylation of kinases is a common theme (for example, Btk kinase 56 ), and thus rapid breathing motions within the kinase appear to play an important role in enabling such processes.
Removal of the myristoyl group has a pronounced effect on the population of the activated state, which increases to ~40% and thus stimulates the Abl kinase activity (Fig. 6a) . Interestingly, our data suggested that the population of the activated state in Bcr-Abl, a fusion with the first 45 residues of Abl removed (equivalent to the Abl ∆capPxxP variant) was only ~30% (considering only the effect caused by the deletion of the cap region), and most of the molecules (~70%) remained in the A r t i c l e s assembled, inhibited state (Fig. 6a) . This finding explains previous genetic observations 7,13,57 that mutations perturbing intramolecular surfaces can confer imatinib resistance in Bcr-Abl, because regulatory constraints are still operational. The disordered region in the RM of Src, in addition to being myristoylated and phosphorylated, plays a role in interacting with proteins and lipids. Recent reports have shown that the region is also involved in interactions with the modular domains within the RM that may fine-tune Src kinase activity 58 . These findings further highlight the functional similarity between Abl and Src kinases 59 . The quantitative dissection of the allosteric regulatory mechanism in Abl presented here revealed a hitherto-unknown intramolecular activating region (cap PxxP ) in the cap. It is likely that the recently reported A19V drugresistance mutation 60 located in the cap PxxP element exerts its function by promoting the activated state of Abl by means of cap PxxP . In this case, the underlying mechanism would be similar to that used by the allosteric drug-resistance mutations located in the connector SH3/2 and linker SH2-KD of the Abl RM (Fig. 5) .
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Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
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